As of 2024-12-11, the Relative Valuation of Ortho Regenerative Technologies Inc (ORTH.CN) is (0.65) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.25 CAD, the upside of Ortho Regenerative Technologies Inc based on Relative Valuation is -361.2%.
The range of the Relative Valuation is (0.27) - (1.04) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.2x - 8.5x | 5.4x |
| Forward P/E multiples | 2.2x - 8.5x | 5.4x |
| Fair Price | (0.27) - (1.04) | (0.65) |
| Upside | -207.4% - -515.0% | -361.2% |
| Date | P/E |